After an incredibly successful event in 2017, this year’s Silver Lining Ride has an even bigger challenge in store for the 12 riders taking part—a 7-day journey from Canberra to Melbourne, and all with the goal of raising $150,000 for ovarian cancer research.
Founded by Georgie Herbert and family friend Clint Stanaway, along with John Hatzis, it was a way to find a silver lining in tragic circumstances. They had all lost their loved ones to ovarian cancer, just weeks apart.
Inspired by two amazing women
Mandy Herbert (Georgie’s mum) and Helen Hatzis (John’s wife) had become close friends, both understanding each other’s struggles as they battled the ‘Beastie’—ovarian cancer—side by side for years. Tackling the disease not only with vigour, but with their trademark humour, they formed Mands’ Mob, hosting dinners, trivia nights and taking part in fun runs, all to raise funds for the OCRF. Over the years, these inspiring women rallied those around them to raise over $400,000 for the cause.
Devastatingly, Helen lost her 11-year battle in December 2016, and Mandy passed away only a few weeks later. Determined to carry on the fundraising spirit that Mands’ Mob had created, the Silver Lining Ride was born.
Evolution of the Silver Lining Ride
In October 2017, nine riders set out on a 10-day journey from Adelaide to Melbourne, travelling 1,067.9km and raising over $120,000 for the OCRF. Led by Georgie, who had never ridden in her life, and John, pulling into Melbourne on that 10th day was an incredible achievement.
This year’s event is an even greater challenge—more hills, more riders, and a bigger target: $150,000. Stopping in at six checkpoints along the way, they’ll also be spreading awareness throughout their fundraising effort.
The 2018 route
Day 1: Canberra to Murrumburrah
Day 2: Murrumburrah to Wagga
Day 3: Wagga to Albury
Day 4: Albury to Shepparton
Day 5: Shepparton to Bendigo
Day 6: Bendigo to Romsey
Day 7: Romsey to MCG
We’re wishing all participants the best of luck on this year’s ride, and towards their goal of $150,000 that will fund innovative ovarian cancer research.